摘要
目的比较茵栀黄口服液与茵陈蒿汤加减防治母婴ABO血型不合的临床疗效。方法 193例母婴ABO血型不合的孕妇分成两组,100例给予茵栀黄口服液治疗,其余93例给予茵陈蒿汤加减治疗。参照国际通用标准技术,监测治疗前后两组孕妇血清Ig G抗体效价及新生儿溶血发生率。结果茵栀黄治疗组的总有效率显著高于茵陈蒿汤加减治疗组(P<0.05),新生儿溶血发生率显著低于茵陈蒿汤加减治疗组(P<0.05)。结论茵栀黄口服液在防治母婴ABO血型不合方面有更好的临床疗效。
Objective To compare the clinical efficacy of Yinzhihuang oral liquids with Yinchenhao decoctions on treating ABO incompatibility. Methods One hundred and ninty-three cases of ABO incompatibility pregnant women were randomly divided into Yinzhihuang oral liquids treatment group (100 cases) and Yinchenhao decoctions treatment group (93 cases), then gravida's serum anti-IgG A/B and neonatal hemolysis were detected. 'Results There was a significant difference between the two treatment groups in efficacy and neonatal morbidity (P〈0.05). Conclusion Yinzhihuang oral liquids may have better effect on treating ABO incompatibility.
出处
《世界临床药物》
CAS
2015年第9期628-630,共3页
World Clinical Drug